Cluster Headache Treatment Survey
1 other identifier
observational
2,487
1 country
1
Brief Summary
The objective of this study is to survey patients with cluster headache about treatment effectiveness and their views on treatments. Participants will complete one brief questionnaire online.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 29, 2023
CompletedFirst Submitted
Initial submission to the registry
August 19, 2023
CompletedFirst Posted
Study publicly available on registry
August 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2025
CompletedFebruary 18, 2026
February 1, 2026
2 years
August 19, 2023
February 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Effectiveness of cluster headache treatment as assessed by a survey
at the time of survey completion, expected to be 6-12 months
Secondary Outcomes (1)
Opinions on new cluster headache treatment as assessed by a survey
at the time of survey completion, expected to be 6-12 months
Study Arms (1)
Patients with episodic or chronic cluster headache
Patients with a diagnosis of episodic or chronic cluster headache, as diagnosed by a health care professional and to be confirmed by questions on the study survey.
Eligibility Criteria
The population is patients with episodic or chronic cluster headache that has been diagnosed by a health care professional. The cluster headache diagnosis will be verified via the survey using a validated cluster headache diagnostic screen.
You may qualify if:
- Patients with episodic or chronic cluster headache that has been diagnosed by a health care professional (no documentation is needed, participant must simply state that he or she has been diagnosed)
You may not qualify if:
- Unable to speak English (the survey is only in English)
- Unable to use a computer to take the online survey
- Unable to provide consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark J Burish, MD, PhD
The University of Texas Health Science Center, Houston
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 19, 2023
First Posted
August 25, 2023
Study Start
June 29, 2023
Primary Completion
June 28, 2025
Study Completion
June 28, 2025
Last Updated
February 18, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share